ArticleSensors (Basel, Switzerland)2023
How to Build Live-Cell Sensor Microdevices.
Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a lot of discussion on how viruses (such as influenza and SARS-CoV-2) are transmitted in air, potentially from aerosols and respiratory droplets, and thus it is important to monitor the environment for the presence of an active pathogen. Currently, the presence of viruses is being determined using primarily nucleic acid-based detection methods, such as reverse transcription- polymerase chain reaction (RT-PCR) tests. Antigen tests have also been developed for this purpose. However, most nucleic acid and antigen methods fail to discriminate between a viable and a non-viable virus. Therefore, we present an alternative, innovative, and disruptive approach involving a live-cell sensor microdevice that captures the viruses (and bacteria) from the air, becomes infected by them, and emits signals for an early warning of the presence of pathogens. This perspective outlines the processes and components required for living sensors to monitor the presence of pathogens in built environments and highlights the opportunity to use immune sentinels in the cells of normal human skin to produce monitors for indoor air pollutants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.